NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) — According to a new market research report titled “Protein Expression Market by System (Prokaryotic Expression Systems, Mammalian Cell Expression Systems, Insect Cell Expression Systems, Yeast Expression Systems, Cell-Free Expression Systems, Algal-Based Expression Systems), by Product & Services (Reagents, Expression Vectors, Competent Cells, Services, Instruments), by Application (Therapeutic, Industrial, Research), by End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Contract Research Organizations), by Geography (US, Canada, UK, Germany, France, Italy, Spain, China, India, Japan, Brazil, Mexico, South Africa) – Global Market Size, Share, Development, Growth and Demand Forecast, 2013-2023” published by P&S Market Research, the protein expression market is expected to grow at a CAGR of 11.7% during 2017 – 2023.
Browse full research report with Detailed TOC on Protein Expression Market: https://www.psmarketresearch.com/market-analysis/protein-expression-market
According to the study, the global protein expression market is likely to grow from $1.4 billion in 2016 to $3.0 billion by 2023. Major key players in the market are developing products with technically advanced features that are designed to produce high protein yield, maintaining a balance of speed and scalability, thereby enhancing its application in the drug development workflow.
As per the findings of the research, prokaryotic expression system occupied the largest share of the protein expression market in 2016, due to the high use of prokaryotic protein expression systems, since they are cheaper as compared to other expression systems
Pharmaceutical & biotechnology companies were the largest end user of the protein expression products in 2016, mainly due to the technological advancement in protein expression research and rising production of recombinant therapeutic proteins for disease treatment.
Geographically, North America has been the largest market for protein expression, with the U.S. being the larger contributor to the regional market, as compared to Canada. The dominant position of the North American market is mainly attributable to the rise in R&D infrastructure, increased aging population, rise in healthcare expenditure and increasing prevalence of chronic diseases in the region.
Europe is the second largest market for protein expression, after North America. The Germany has been the largest contributor to the European protein expression market, followed by the U.K. and France. The growth of the European market is mainly attributable to the growing aging population, increase in infections, rising incidences of cardiovascular diseases, chronic pain, and neurological disorders and R&D infrastructure. The protein expression market is expected to witness the fastest growth in Asia-Pacific during forecast period. Rising prevalence of diseases such as cardiovascular disease and diabetes, increasing R&D spending, growing aging population and increasing per capita income are some of the driving factors boosting the Asia-Pacific market.
Request for Sample Pages: https://www.psmarketresearch.com/market-analysis/protein-expression-market/report-sample
Key players are launching new products in the market to offer advanced protein expression products. In August 2017, Thermo Fisher Scientific Inc. launched Thermo Scientific Krios G3i which is designed to deliver innovative enhancements necessary for rapid adoption of cryo-EM. The Thermo Scientific Krios G3i can be used independently or together in a single particle analysis workflow to make structural analysis of the proteins, protein complexes and other biomolecular structures faster, easier and more accessible.
Some of the other key players operating in this industry include Merck KGaA, Genscript Biotech Corporation, Agilent Technologies, Inc., Promega Corporation, Bio-Rad Laboratories, Inc., Qiagen N.V., New England Biolabs Inc., and Lonza Group Ltd.
Browse Related Research at:
Oligonucleotide Synthesis Market
The global oligonucleotide synthesis market is likely to grow from $1.3 billion in 2016 to $2.7 billion by 2023. Recent technological and other advances, leading to cost effective and rapid synthesis of oligomers, increased government funding and other initiatives, have been driving the global oligonucleotide synthesis market. The market is further expected to gain revenue from increased focus on personalized medicine, offering tailored medical treatment to individual characteristics, needs and preferences of patients and rising compliance for oligonucleotide synthesis in the emerging economies.
Microbial Identification Market
The increasing incidence of infectious diseases is playing a key role in the growth of the global microbial identification market. Infectious diseases are caused due to pathogenic microorganisms, such as fungi, bacteria, viruses and parasites. Tuberculosis, hepatitis, measles, malaria and HIV are some of the infectious diseases caused due to microorganisms. Microbial infection is the common cause of millions of deaths and demanding increasing healthcare resources leading to increase in healthcare cost.
About P&S Market Research
P&S Market Research is a market research company, which offers market research and consulting services for various geographies around the globe. We provide market research reports, industry forecasting reports, business intelligence, and research based consulting services across different industry/business verticals.
As one of the top growing market research agency, we’re keen upon providing market landscape and accurate forecasting. Our analysts and consultants are proficient with business intelligence and market analysis, through their interaction with leading companies of the concerned domain. We help our clients with B2B market research and assist them in identifying various windows of opportunity, and framing informed and customized business expansion strategies in different regions.
Manager – Client Partner
347, 5th Ave. #1402
New York City, NY – 10016
Toll-Free: +1-888-778-7886 (USA/Canada)
Email: [email protected]
Connect with us: LinkedIn | Twitter | Google + | Facebook
Latest posts by Nasdaq NewsFeed (see all)
- Global RX-to-OTC Switching Market Current and Future Trends Report 2017 with Insight from Key Industry Opinion Leaders - November 23, 2017
- CORRECTION of Notice (764/17): Listing of bond loan issued by Fastighets AB Balder (publ) on STO Corporate Bonds (772/17) - November 23, 2017
- Refinancing of RenteMax-loans - November 23, 2017